Blood and imaging biomarkers of blood-brain barrier disruption in diabetic individuals with cognitive impairment
Aging Clinical and Experimental Research · 20.01.2026 · 38 (1)
DOI: 10.1007/s40520-025-03316-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Clinical and Experimental Research, online erschienen am 20.01.2026. Verfasst von Luyao Qiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Diabetes Mellitus, Type 2, Cognitive Dysfunction, Receptor, Platelet-Derived Growth Factor beta. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Science and Technology Innovation 2030 - Major Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Blood-brain barrier (BBB) disruption is a recognized contributor to neurodegenerative diseases. However, its specific role in cognitive decline in diabetes has not been sufficiently explored. AIMS: This study aimed to evaluate the association between BBB integrity and cognitive function and to investigate the discriminative ability of BBB-related biomarkers for cognitive impairment in individuals with type 2 diabetes mellitus (T2DM). METHODS: In this case-control study, participants were recruited from the Second Affiliated Hospital of Nanchang University. All subjects underwent dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). We compared quantitative brain imaging (Ktrans and Ve) and serum platelet-derived growth factor receptor β (PDGFRβ) between diabetic individuals with and without cognitive impairment. The relationships between these biomarkers and cognitive performance were assessed using linear regression analyses. The discriminative capacity of each biomarker for distinguishing groups was evaluated using receiver operating characteristic (ROC) curve analysis. RESULTS: T2DM individuals with cognitive impairment exhibited significantly elevated Ktrans and Ve levels compared to those without, which correlated inversely with MoCA scores in key brain regions. Serum PDGFRβ was also independently associated with impaired cognition. Every biomarker individually demonstrated high discriminative power for evaluating cognitive status, with AUC values of 0.908 (95% CI: 0.842 to 0.973) for Ktrans, 0.923 (95% CI: 0.86 to 0.986) for Ve, and 0.839 (95% CI: 0.751 to 0.928) for PDGFRβ. CONCLUSIONS: Our results confirm the critical role of BBB dysfunction in diabetic cognitive impairment. The biomarkers serum PDGFRβ, Ktrans, and Ve showed potential associations with this condition, suggesting their clinical value for future clinical application in risk stratification and therapeutic monitoring in T2DM population. TRN: ChiCTR2400085417, 2024.06.06, retrospectively registered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Nanchang Key Laboratory of Medical-Engineering Integration and Clinical Translation, Nanchang, China, 330006.
- Department of Neurology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. tangzyjr@163.com.
- Nanchang Key Laboratory of Medical-Engineering Integration and Clinical Translation, Nanchang, China, 330006. tangzyjr@163.com.
Förderung
- the Science and Technology Innovation 2030 - Major Project
- National Natural Science Foundation of China
Zitieren
APA
Qiao, L., Tang, X., Peng, J., Xie, Q., Wu, M., & Tang, Z. (2026). Blood and imaging biomarkers of blood-brain barrier disruption in diabetic individuals with cognitive impairment. Aging Clinical and Experimental Research, 38(1). https://doi.org/10.1007/s40520-025-03316-w
Vancouver
Qiao L, Tang X, Peng J, Xie Q, Wu M, Tang Z. Blood and imaging biomarkers of blood-brain barrier disruption in diabetic individuals with cognitive impairment. Aging Clinical and Experimental Research. 2026;38(1). doi:10.1007/s40520-025-03316-w
BibTeX
@article{Qiao2026,
author = {Qiao, Luyao and Tang, Xiaoping and Peng, Jiaxing and Xie, Qing and Wu, Mengqian and Tang, Zhenyu},
title = {Blood and imaging biomarkers of blood-brain barrier disruption in diabetic individuals with cognitive impairment},
journal = {Aging Clinical and Experimental Research},
year = {2026},
volume = {38},
number = {1},
doi = {10.1007/s40520-025-03316-w}
}
EUVIMED